首页> 美国卫生研究院文献>PLoS Clinical Trials >Comparative effectiveness of warfarin, dabigatran, rivaroxaban and apixaban in non-valvular atrial fibrillation: A nationwide pharmacoepidemiological study

【2h】

Comparative effectiveness of warfarin, dabigatran, rivaroxaban and apixaban in non-valvular atrial fibrillation: A nationwide pharmacoepidemiological study

机译：华法林，达比加群，利伐沙班和阿哌沙班在非瓣膜性心房颤动中的比较有效性：一项全国性药物流行病学研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectiveTo compare effectiveness and safety of warfarin and the direct oral anticoagulants (DOAC) dabigatran, rivaroxaban and apixaban in non-valvular atrial fibrillation in routine care.

机译：目的比较华法林和直接口服抗凝剂（DOAC）达比加群，利伐沙班和阿哌沙班在常规治疗中非瓣膜性心房颤动的有效性和安全性。

著录项

期刊名称 PLoS Clinical Trials
作者
Lars J. Kjerpeseth; Randi Selmer; Inger Ariansen; Øystein Karlstad; Hanne Ellekjær; Eva Skovlund;
展开▼
作者单位

展开▼
年(卷),期 2012(14),8
年度 2012
页码 e0221500
总页数 18
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. The risk of acute kidney injury in Asians treated with apixaban, rivaroxaban, dabigatran, or warfarin for non-valvular atrial fibrillation: A nationwide cohort study in Taiwan [J] . Chan Yi-Hsin, Yeh Yung-Hsin, Hsieh Mei-Yun, International Journal of Cardiology . 2018,第期

机译：亚洲人急性肾损伤的风险，用亚麻黄醛，罗昔扎班，达比税素或Warfarin进行非瓣膜心房颤动：台湾全国队列研究
2. Apixaban, dabigatran, and rivaroxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: A cost-effectiveness analysis [J] . RognoniC., MarchettiM., QuagliniS., Clinical drug investigation . 2014,第1期

机译：阿哌沙班，达比加群和利伐沙班与华法林与华法林在非瓣膜性心房颤动中预防卒中的成本效益分析
3. Major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a "real-world" observational study in the United States [J] . Lip Gregory Y. H., Pan Xianying, Kamble Shital, International journal of clinical practice . 2016,第9期

机译：由阿哌沙班，达比加群，利伐沙班或华法林引发的非瓣膜性房颤患者的主要出血风险：一项在美国的“真实世界”观察性研究
4. Epicardial Pulmonary Vein Isolation By Cryoablation As Concomitant Cardiac Surgery To Treat Non-valvular Atrial Fibrillation "Lavie Technique" [C] . H. Kubota, M. Sato, T. Fujiki, World Congress on Cardiac Pacing and Electrophysiology . 2003

机译：心外膜肺静脉隔离通过冷冻剂作为伴随心脏手术治疗非瓣膜心房颤动“Lavie技术”
5. Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for the prevention of stroke prophylaxis in atrial fibrillation. [D] . Harrington, Amanda. 2012

机译：阿哌沙班，达比加群，利伐沙班和华法林预防房颤预防中风的成本效益。
6. Comparative effectiveness of dabigatran rivaroxaban apixaban and warfarin in the management of patients with non-valvular atrial fibrillation [O] . Joshua Pink, Munir Pirmohamed, Dyfrig A. Hughes -1

机译：达比加群利伐沙班阿哌沙班和华法林在非瓣膜性房颤患者管理中的比较有效性
7. Comparative effectiveness of warfarin, dabigatran, rivaroxaban and apixaban in non-valvular atrial fibrillation: A nationwide pharmacoepidemiological study [O] . Lars J. Kjerpeseth, Randi Selmer, Inger Ariansen, 2019

机译：Warfarin，Dabigatran，Rivaroxaban和非瓣膜心房颤动中紫杉醇的比较有效性：全国性药物遗传学研究

Comparative effectiveness of warfarin, dabigatran, rivaroxaban and apixaban in non-valvular atrial fibrillation: A nationwide pharmacoepidemiological study

摘要

著录项

相似文献

相关主题

期刊订阅